Stay updated on Personalized Neoantigen Cancer Vaccine Clinical Trial
Sign up to get notified when there's something new on the Personalized Neoantigen Cancer Vaccine Clinical Trial page.

Latest updates to the Personalized Neoantigen Cancer Vaccine Clinical Trial page
- Check2 days agoChange DetectedAdded detailed trial locations, listing sites across Arizona, Florida, Illinois, Minnesota, New York, Ohio, Tennessee, Texas, Virginia, and Victoria, Australia. The revision version updated from v3.3.2 to v3.3.3.SummaryDifference1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedPublications section now states that entries are automatically filled from PubMed, and a new Revision: v3.3.2 label is shown; the previous PubMed wording and older revision label were removed.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the general government funding and NIH operations notice; the page's study details and links remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check53 days agoChange DetectedCore study information appears unchanged between the screenshots. Only minor formatting adjustments are visible.SummaryDifference0.4%

- Check82 days agoChange DetectedUpdate to v3.2.0 with a government funding lapse notice and open status of NIH Clinical Center; removes v3.1.0.SummaryDifference4%

- Check89 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Personalized Neoantigen Cancer Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Personalized Neoantigen Cancer Vaccine Clinical Trial page.